T1	intervention 0 20	Topical atorvastatin
T2	condition 42 55	skin toxicity
T3	eligibility 59 113	patients receiving radiation therapy for breast cancer
T4	No-of-participants 406 413	Seventy
T5	control 485 497	placebo gels
T6	outcome-Measure 531 559	Radiation-induced dermatitis
T7	outcome-Measure 653 669	pain and itching
T8	outcome 804 878	reduced significantly radiation-induced breast swelling, itching, and pain
T9	outcome 956 998	reduced the redness caused by radiotherapy
